Last $74.29 USD
Change Today -0.69 / -0.92%
Volume 1.9M
BAX On Other Exchanges
Symbol
Exchange
New York
Berlin
SIX Swiss Ex
Mexico
As of 6:40 PM 09/2/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Robert M. Davis J.D.

Chief Financial Officer and Executive Vice President, Merck & Co. Inc.
AgeTotal Calculated CompensationThis person is connected to 131 board members in 2 different organizations across 4 different industries.

See Board Relationships
47--

Background*

Mr. Robert M. Davis, also known as Rob, has been Chief Financial Officer and Executive Vice President at Merck & Co. Inc. since April 23, 2014. He is an Advisor at HealthQuest Capital. Mr. Davis served as Corporate Vice President at Baxter International Inc. from May 17, 2006 to March 27, 2014 and also served as its President at Medical Products from October 2010 to March 27, 2014. Mr. Davis served as the President at Renal at Baxter International Inc. from July 5, ...

Read Full Background

Corporate Headquarters*

One Baxter Parkway
Deerfield, Illinois 60015

United States

Phone: 224-948-2000
Fax: 224-948-1813

Board Members Memberships*

Trustee
Director

Education*

Bachelor's Degree
Miami University
JD
Northwestern University School of Law
MBA
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BAX:US $74.29 USD -0.69

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Christopher A. Viehbacher Chief Executive Officer, Director and Member of Strategy Committee
Sanofi
€3.0M
Severin Schwan Ph.D.Chief Executive Officer and Director
Roche Holding AG
SFr.5.1M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAXTER INTERNATIONAL INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.